2-{1-(tert-Butoxycarbonyl)-4-[2-(trifluoromethyl)phenyl] piperidin-4-yl}acetic acid, >95%, 1g

2,3-Dibromo-5-fluorotoluene, 95.0%, 5g

2-((Benzyloxy)methyl)cyclopropanecarboxylic acid, 95.0%, 1g

5-Chloroisoindolin-1-one, 95.0%, 5g

2,4,5-Trifluoronitrobenzene, 99.0%, 25g

Kojic acid, 99.0%, 5g

Methyl 5-bromopyrazine-2-carboxylate, 98.0%, 5g

Diethylenetriamine, min. 98%, for synthesis, 2.5 L, glass packaging

(S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride, 97%, 5g

4-(Methylsulfonyl)-2-(pyrrolidin-1-yl)benzoic acid, 98%, 1g

5-Cyclopropyl-1,2,4-oxadiazole-3-carboxylic acid, 95%, 250mg

Cyclopropylisocyanide, 96.0%, 1g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline, 95.0%, 10g